Literature DB >> 10930921

The role of colour Doppler ultrasonography in detecting prostate cancer.

K Shigeno1, M Igawa, H Shiina, H Wada, T Yoneda.   

Abstract

OBJECTIVE: To determine the usefulness of colour Doppler ultrasonography (CDUS) in detecting prostate cancer, by comparing CDUS with grey-scale transrectal ultrasonography (TRUS) and magnetic resonance imaging (MRI). PATIENTS AND METHODS: In all, 278 patients who underwent prostate biopsies because of an abnormal digital rectal examination, elevated prostate specific antigen levels, and/or abnormal TRUS between May 1998 and November 1999 were evaluated. The diagnostic accuracies of TRUS, CDUS, MRI and combinations of these imaging techniques in detecting prostate cancer were compared, based on the biopsy results.
RESULTS: Carcinoma was detected in 233 of 1696 specimens, and 87 patients were diagnosed with prostate cancer. For each detected cancer site, the sensitivity of CDUS was lower than those of other imaging techniques, but CDUS had high a specificity and positive predictive value. The combination of grey-scale TRUS and CDUS or MRI improved the sensitivity and negative predictive value. The specificity and positive predictive value of the combination of grey-scale TRUS and MRI were less than those for grey-scale TRUS alone, while those for the combination of grey-scale TRUS and CDUS were higher than those for grey-scale TRUS alone. Five tumours were isoechoic but seen as hypervascular lesions with CDUS.
CONCLUSION: CDUS provides information useful for detecting prostate cancer when used in combination with grey-scale TRUS, and should be included in the routine examination for prostate cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10930921     DOI: 10.1046/j.1464-410x.2000.00829.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

Review 1.  Methods for volume assessment of prostate cancer.

Authors:  Heinz-Peter Schlemmer; Stefan Corvin
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

Review 2.  Image guidance for focal therapy of prostate cancer.

Authors:  U Lindner; N Lawrentschuk; J Trachtenberg
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

Review 3.  Contrast specific imaging in the detection and localization of prostate cancer.

Authors:  Hessel Wijkstra; Margot H Wink; Jean J M C H de la Rosette
Journal:  World J Urol       Date:  2004-10-05       Impact factor: 4.226

Review 4.  How to improve prostate biopsy detection of prostate cancer.

Authors:  D K Ornstein; J Kang
Journal:  Curr Urol Rep       Date:  2001-06       Impact factor: 3.092

5.  Quantitative colour Doppler and greyscale ultrasound for evaluating prostate cancer.

Authors:  Khalid Ashi; Brooke Kirkham; Anil Chauhan; Susan M Schultz; Bonnie J Brake; Chandra M Sehgal
Journal:  Ultrasound       Date:  2020-09-09

6.  Evaluation of Prostatic Lesions by Transrectal Ultrasound, Color Doppler, and the Histopathological Correlation.

Authors:  Sachin Khanduri; Gaurav Katyal; Aakshit Goyal; Saurav Bhagat; Santosh Yadav; Tarim Usmani; Nikita Singh; Mriganki Chaudhary; Shobha Khanduri
Journal:  Cureus       Date:  2017-07-03

7.  Computer-aided assessment of regional vascularity of thyroid nodules for prediction of malignancy.

Authors:  Faisal N Baig; Jurgen T J van Lunenburg; Shirley Y W Liu; Shea-Ping Yip; Helen K W Law; Michael Ying
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

8.  Transrectal Ultrasound and Photoacoustic Imaging Probe for Diagnosis of Prostate Cancer.

Authors:  Jihun Jang; Jinwoo Kim; Hak Jong Lee; Jin Ho Chang
Journal:  Sensors (Basel)       Date:  2021-02-09       Impact factor: 3.576

9.  Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer.

Authors:  Yozo Mitsui; Inik Chang; Taku Kato; Yutaka Hashimoto; Soichiro Yamamura; Shinichiro Fukuhara; Darryn K Wong; Marisa Shiina; Mitsuho Imai-Sumida; Shahana Majid; Sharanjot Saini; Hiroaki Shiina; Koichi Nakajima; Guoren Deng; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Oncotarget       Date:  2016-08-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.